rs141727248

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_004924.6(ACTN4):​c.2401G>A​(p.Val801Met) variant causes a missense change. The variant allele was found at a frequency of 0.00579 in 1,612,964 control chromosomes in the GnomAD database, including 29 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another nucleotide change resulting in the same amino acid substitution has been previously reported as Uncertain significance in ClinVar.

Frequency

Genomes: 𝑓 0.0038 ( 2 hom., cov: 31)
Exomes 𝑓: 0.0060 ( 27 hom. )

Consequence

ACTN4
NM_004924.6 missense

Scores

5
12

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:12

Conservation

PhyloP100: 3.66

Publications

9 publications found
Variant links:
Genes affected
ACTN4 (HGNC:166): (actinin alpha 4) Alpha actinins belong to the spectrin gene superfamily which represents a diverse group of cytoskeletal proteins, including the alpha and beta spectrins and dystrophins. Alpha actinin is an actin-binding protein with multiple roles in different cell types. In nonmuscle cells, the cytoskeletal isoform is found along microfilament bundles and adherens-type junctions, where it is involved in binding actin to the membrane. In contrast, skeletal, cardiac, and smooth muscle isoforms are localized to the Z-disc and analogous dense bodies, where they help anchor the myofibrillar actin filaments. This gene encodes a nonmuscle, alpha actinin isoform which is concentrated in the cytoplasm, and thought to be involved in metastatic processes. Mutations in this gene have been associated with focal and segmental glomerulosclerosis. [provided by RefSeq, Jul 2008]
ACTN4 Gene-Disease associations (from GenCC):
  • focal segmental glomerulosclerosis 1
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
  • familial idiopathic steroid-resistant nephrotic syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.011119425).
BP6
Variant 19-38728009-G-A is Benign according to our data. Variant chr19-38728009-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 259574.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00383 (583/152150) while in subpopulation NFE AF = 0.00634 (431/67960). AF 95% confidence interval is 0.00585. There are 2 homozygotes in GnomAd4. There are 260 alleles in the male GnomAd4 subpopulation. Median coverage is 31. This position passed quality control check.
BS2
High AC in GnomAd4 at 583 AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_004924.6. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ACTN4
NM_004924.6
MANE Select
c.2401G>Ap.Val801Met
missense
Exon 19 of 21NP_004915.2
ACTN4
NM_001440296.1
c.2401G>Ap.Val801Met
missense
Exon 19 of 22NP_001427225.1
ACTN4
NM_001440300.1
c.2401G>Ap.Val801Met
missense
Exon 19 of 22NP_001427229.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ACTN4
ENST00000252699.7
TSL:1 MANE Select
c.2401G>Ap.Val801Met
missense
Exon 19 of 21ENSP00000252699.2
ACTN4
ENST00000424234.7
TSL:1
c.2401G>Ap.Val801Met
missense
Exon 19 of 21ENSP00000411187.4
ACTN4
ENST00000390009.7
TSL:1
c.1744G>Ap.Val582Met
missense
Exon 12 of 14ENSP00000439497.1

Frequencies

GnomAD3 genomes
AF:
0.00383
AC:
583
AN:
152032
Hom.:
2
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.00123
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00236
Gnomad ASJ
AF:
0.000864
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00481
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00634
Gnomad OTH
AF:
0.00526
GnomAD2 exomes
AF:
0.00365
AC:
906
AN:
248452
AF XY:
0.00384
show subpopulations
Gnomad AFR exome
AF:
0.00125
Gnomad AMR exome
AF:
0.00203
Gnomad ASJ exome
AF:
0.00160
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00504
Gnomad NFE exome
AF:
0.00605
Gnomad OTH exome
AF:
0.00231
GnomAD4 exome
AF:
0.00600
AC:
8763
AN:
1460814
Hom.:
27
Cov.:
32
AF XY:
0.00583
AC XY:
4237
AN XY:
726686
show subpopulations
African (AFR)
AF:
0.000807
AC:
27
AN:
33478
American (AMR)
AF:
0.00235
AC:
105
AN:
44688
Ashkenazi Jewish (ASJ)
AF:
0.00126
AC:
33
AN:
26132
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39688
South Asian (SAS)
AF:
0.0000812
AC:
7
AN:
86182
European-Finnish (FIN)
AF:
0.00637
AC:
335
AN:
52624
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5768
European-Non Finnish (NFE)
AF:
0.00716
AC:
7964
AN:
1111886
Other (OTH)
AF:
0.00484
AC:
292
AN:
60368
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.472
Heterozygous variant carriers
0
488
977
1465
1954
2442
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
300
600
900
1200
1500
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00383
AC:
583
AN:
152150
Hom.:
2
Cov.:
31
AF XY:
0.00350
AC XY:
260
AN XY:
74382
show subpopulations
African (AFR)
AF:
0.00123
AC:
51
AN:
41530
American (AMR)
AF:
0.00235
AC:
36
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.000864
AC:
3
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5148
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4820
European-Finnish (FIN)
AF:
0.00481
AC:
51
AN:
10604
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00634
AC:
431
AN:
67960
Other (OTH)
AF:
0.00521
AC:
11
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
30
59
89
118
148
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00519
Hom.:
7
Bravo
AF:
0.00351
ESP6500AA
AF:
0.00136
AC:
6
ESP6500EA
AF:
0.00535
AC:
46
ExAC
AF:
0.00358
AC:
434
Asia WGS
AF:
0.000577
AC:
2
AN:
3478
EpiCase
AF:
0.00529
EpiControl
AF:
0.00570

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:12
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:5
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Mar 09, 2017
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.

Nov 14, 2019
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not provided Benign:5
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Jul 01, 2022
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

ACTN4: BS1, BS2

Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Jan 28, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Focal segmental glomerulosclerosis Benign:1
Jul 11, 2022
Genome Diagnostics Laboratory, The Hospital for Sick Children
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Focal segmental glomerulosclerosis 1 Benign:1
Dec 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.46
BayesDel_addAF
Benign
-0.32
T
BayesDel_noAF
Benign
-0.23
CADD
Uncertain
25
DANN
Uncertain
0.99
DEOGEN2
Benign
0.40
T
Eigen
Benign
-0.10
Eigen_PC
Benign
0.076
FATHMM_MKL
Uncertain
0.90
D
M_CAP
Uncertain
0.17
D
MetaRNN
Benign
0.011
T
MetaSVM
Benign
-0.89
T
MutationAssessor
Benign
1.8
L
PhyloP100
3.7
PrimateAI
Uncertain
0.69
T
PROVEAN
Benign
-0.90
N
REVEL
Benign
0.15
Sift
Benign
0.11
T
Sift4G
Benign
0.064
T
Polyphen
0.013
B
Vest4
0.64
MVP
0.67
MPC
0.84
ClinPred
0.011
T
GERP RS
4.5
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.14
gMVP
0.94
Mutation Taster
=89/11
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs141727248; hg19: chr19-39218649; COSMIC: COSV99062848; COSMIC: COSV99062848; API